Goodbye CFDA, Hello MRA: China Overhauls Regulatory Bodies

 
• By Brian Yang

China proposes to merge its top drug regulator into new combined body, and creates a medical reimbursement agency in move viewed as sign of strengthening regulatory oversight.

Chinese flag
China Proposes A Radical Reorganization Of Drug Regulation

China's State Council has proposed a new reorganization plan that will reduce the number of state agencies overseeing drug regulation, in a new proposal calling for the merger of three agencies including the China FDA (CFDA). 

Per the proposal, the CFDA will be merged with its regulation enforcement agency, the State Administration for Industry and Commerce Administration (SAIC), and its inspection agency, the State Administration for Quality, Safety Inspection and

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Market Access

More from Pink Sheet